Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major
Galanello, R, Piga, A, Forni, GL, Bertrand, Y, Foschini, ML, Bordone, E, Leoni, G, Lavagetto, A, Zappu, A, Longo, F, Maseruka, H, Hewson, N, Sechaud, R, Belleli, R, Alberti, D
Published in Haematologica (Roma) (01.10.2006)
Get full text
Published in Haematologica (Roma) (01.10.2006)
Journal Article